cisplatin or carboplatin + pemetrexed

Phase 3

Phase 3

Development Phase

Upcoming Catalysts

Historical Events

Regulatory Approvals

No catalyst events have been recorded for this drug yet.

Competitive Landscape

0 competitors in Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)

Drug Information

Target Indication

Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)

Clinical Trial

Last updated: 10/21/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science

Mechanism of action & safety profile

Developer

IMMP

Immutep Limited

Related Pipeline

Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)

Breast Carcinoma

Adenocarcinoma Breast Stage IV

Get Catalyst Alerts

Receive weekly digests of upcoming catalysts